Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RK Pharma develops and manufactures high-quality generic pharmaceutical products with a focus on complex formulations. The company operates globally with state-of-the-art facilities in the US and India. It recently expanded its portfolio through the acquisition of VGYAAN Pharmaceuticals LLC in June 2023. The pipeline includes injectables, sterile ophthalmic solutions, dermal products, APIs, and finished dosage forms. Clinical results are not detailed as the primary business model centers around generics rather than novel clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RK Pharma Inc.